SEATTLE GENETICS INC's ticker is SGENXXXX and the CUSIP is 812578102. A total of 299 filers reported holding SEATTLE GENETICS INC in Q1 2017. The put-call ratio across all filers is 0.82 and the average weighting 0.3%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2019 | $1,435,000 | -5.3% | 16,800 | -18.8% | 0.26% | -5.8% |
| Q1 2019 | $1,516,000 | +385.9% | 20,700 | +340.4% | 0.28% | +1154.5% |
| Q2 2018 | $312,000 | -24.5% | 4,700 | -40.5% | 0.02% | -26.7% |
| Q1 2018 | $413,000 | +93.0% | 7,900 | +132.4% | 0.03% | +328.6% |
| Q1 2017 | $214,000 | -8.2% | 3,400 | -34.6% | 0.01% | -91.5% |
| Q4 2015 | $233,000 | – | 5,200 | – | 0.08% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Baker Brothers Advisors | 50,060,240 | $5,775,950,000 | 35.57% |
| Lagoda Investment Management, L.P. | 72,969 | $8,419,000 | 9.97% |
| Avidity Partners Management LP | 580,000 | $66,920,000 | 9.25% |
| Arabesque Asset Management Ltd | 14,807 | $1,708,000 | 3.53% |
| Boxer Capital, LLC | 400,000 | $46,152,000 | 3.15% |
| Woodline Partners LP | 364,333 | $42,037,000 | 3.00% |
| INTERNATIONAL BIOTECHNOLOGY TRUST PLC | 56,900 | $6,557,000 | 2.99% |
| SECTORAL ASSET MANAGEMENT INC | 107,000 | $12,346,000 | 2.37% |
| Capital International, Inc./CA/ | 1,197,659 | $138,186,000 | 2.33% |
| Bain Capital Public Equity Management II, LLC | 169,641 | $19,573,000 | 2.29% |